144 related articles for article (PubMed ID: 23765687)
1. Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model.
Ueda T; Ito S; Shiraishi T; Kulkarni P; Ueno A; Nakagawa H; Kimura Y; Hongo F; Kamoi K; Kawauchi A; Miki T
Prostate; 2013 Sep; 73(13):1403-12. PubMed ID: 23765687
[TBL] [Abstract][Full Text] [Related]
2. The developmental expression profile of PAX2 in the murine prostate.
Chen Q; DeGraff DJ; Sikes RA
Prostate; 2010 May; 70(6):654-65. PubMed ID: 20017165
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
Bose SK; Gibson W; Giri S; Nath N; Donald CD
Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
[TBL] [Abstract][Full Text] [Related]
4. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
[TBL] [Abstract][Full Text] [Related]
5. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
7. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
Lin D; Watahiki A; Bayani J; Zhang F; Liu L; Ling V; Sadar MD; English J; Fazli L; So A; Gout PW; Gleave M; Squire JA; Wang YZ
Cancer Res; 2008 Jun; 68(11):4352-9. PubMed ID: 18519696
[TBL] [Abstract][Full Text] [Related]
8. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the metastasis-associated gene Ehm2 in prostate cancer.
Wang J; Cai Y; Penland R; Chauhan S; Miesfeld RL; Ittmann M
Prostate; 2006 Nov; 66(15):1641-52. PubMed ID: 16927306
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
12. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
14. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
15. Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.
Khoubehi B; Kessling AM; Adshead JM; Smith GL; Smith RD; Ogden CW
J Urol; 2001 Jun; 165(6 Pt 1):2115-20. PubMed ID: 11371938
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
17. IgG gene expression and its possible significance in prostate cancers.
Liu Y; Chen Z; Niu N; Chang Q; Deng R; Korteweg C; Gu J
Prostate; 2012 May; 72(6):690-701. PubMed ID: 22430367
[TBL] [Abstract][Full Text] [Related]
18. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
[TBL] [Abstract][Full Text] [Related]
19. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.
Stumm L; Burkhardt L; Steurer S; Simon R; Adam M; Becker A; Sauter G; Minner S; Schlomm T; Sirma H; Michl U
J Clin Pathol; 2013 Jul; 66(7):563-8. PubMed ID: 23559350
[TBL] [Abstract][Full Text] [Related]
20. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]